USE OF CSAIDS IN RHINOVIRUS INFECTION

The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment of symptoms of the common cold and the exacerbation of symptoms associated therewith in humans.

Saved in:
Bibliographic Details
Main Authors GRIEGO, SANDRA, D, DILLON, SUSAN, B
Format Patent
LanguageEnglish
French
German
Published 24.07.2002
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment of symptoms of the common cold and the exacerbation of symptoms associated therewith in humans.
Bibliography:Application Number: EP20000965060